Plasbumin United States
United States

 Advanced Search

Print this Page

Plasbumin®-20 contains a four-fold greater concentration, and Plasbumin®-25 a five-fold greater concentration of colloidal proteins than Plasbumin®-5 and Plasmanate®, and are capable of pulling more fluid back into the circulatory system from the spaces surrounding tissue cells. Plasbumin®-20, Plasbumin®-25, Plasbumin®-5, and Plasmanate® all contain approximately 145 mEq/L of sodium.

Plasbumin®-25 and Plasbumin®-20 are also used in the treatment of shock, injuries in which shock may occur, and for hypoproteinemia. Plasbumin®-25 contains 25% albumin in solution and Plasbumin®-20 contains 20% albumin in solution. Both are pasteurized, stabilized, and buffered in a similar manner to the 5% solution.

Plasbumin®-5, Albumin (Human) 5%, USP

Plasbumin® Home  |   Healthcare Professionals  |   Excipient Customers  |   Patients
Important Safety Information  |   Prescribing Information  |   Site Map  |   Glossary



Talecris Biotherapeutics
Contact Talecris    General Conditions of Use    Privacy Statement   
This site is intended for US residents only. Non-US residents can go to www.Talecris.com.
© 2009 Talecris Biotherapeutics


 

 

 

 

 

 

Update Flash